Abdominal Obesity Metabolic Syndrome News - LARVOL Sigma

Abdominal Obesity Metabolic Syndrome

Welcome, Profile Billing Logout

56 Mechanisms of Action

«1 2...5 6 7 8 9 10 11 12 13 14 151617 »

||||||||||  pioglitazone / Generic mfg.
Trial termination, IO biomarker:  ADT: Androgen Deprivation Therapy Study (clinicaltrials.gov) -  Aug 2, 2012
P=N/A, N=1, Terminated,  Sponsor: National Institute on Aging (NIA)
Recruiting --> Terminated; No Participants completed study

||||||||||  pioglitazone / Generic mfg.
Enrollment change, IO biomarker:  ADT: Androgen Deprivation Therapy Study (clinicaltrials.gov) -  Aug 2, 2012
P=N/A, N=1, Terminated,  Sponsor: National Institute on Aging (NIA)
Recruiting --> Terminated; No Participants completed study N=60 --> 1

||||||||||  febuxostat / Generic mfg.
New P4 trial:  Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome (clinicaltrials.gov) -  Jul 29, 2012
P4, N=30, Recruiting,  Sponsor: University of Texas Southwestern Medical Center

|||||||||| Enrollment open: ARMOPREVCVR: The Role of a Combination of Nutraceuticals in the Control of Cardiovascular Risk (clinicaltrials.gov) - Jul 23, 2012
P4, N=1500, Recruiting, Sponsor: Federico II University
N=60 --> 1 Active, not recruiting --> Recruiting

|||||||||| Trial initiation date: Healthy Bodies, Healthy Kids (clinicaltrials.gov) - Jul 18, 2012
P=N/A, N=126, Recruiting, Sponsor: Washington University School of Medicine
Active, not recruiting --> Recruiting Initiation date: Mar 2011 --> Jul 2011

|||||||||| Enrollment open: Healthy Bodies, Healthy Kids (clinicaltrials.gov) - Jul 18, 2012
P=N/A, N=126, Recruiting, Sponsor: Washington University School of Medicine
Initiation date: Mar 2011 --> Jul 2011 Not yet recruiting --> Recruiting

||||||||||  beta lapachone (MB-12066) / KT&G Corp
Trial completion:  Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers (clinicaltrials.gov) -  Jul 15, 2012
P1, N=40, Completed,  Sponsor: KT&G Life Sciences Corp
Not yet recruiting --> Recruiting Recruiting --> Completed

|||||||||| Enrollment change: MUFA PUFA: Comparative Effects of 2 Diets in Veterans With the Metabolic Syndrome (clinicaltrials.gov) - Jul 12, 2012
P=N/A, N=70, Active, not recruiting, Sponsor: Department of Veterans Affairs
Recruiting --> Completed N=200 --> 70

|||||||||| Enrollment change: Bioavailability and Biological Effects of Vitamin D2 Contained in Mushroom (clinicaltrials.gov) - Jul 11, 2012
P=N/A, N=47, Completed, Sponsor: Mount Sinai School of Medicine
N=200 --> 70 N=80 --> 47

||||||||||  omzotirome (TRC 150094) / Torrent Pharma
Trial completion:  Hyperinsulinemic Euglycemic Clamp Protocol (clinicaltrials.gov) -  Jul 5, 2012
P2a, N=40, Completed,  Sponsor: Torrent Pharmaceuticals Limited
N=80 --> 47 Not yet recruiting --> Completed

|||||||||| New P4 trial: Obstructive Sleep Apnea in the Absence of Metabolic Syndrome (clinicaltrials.gov) - Jul 4, 2012
P4, N=34, Completed, Sponsor: Associa

|||||||||| Trial completion: OPUS School Meal Study (clinicaltrials.gov) - Jul 3, 2012
P=N/A, N=834, Completed, Sponsor: AAstrup
Not yet recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Januvia (sitagliptin) / Merck (MSD)
Trial completion:  SPHINX: Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome (clinicaltrials.gov) -  Jun 27, 2012
P=N/A, N=82, Completed,  Sponsor: VU University Medical Center
Active, not recruiting --> Completed Recruiting --> Completed

||||||||||  rosiglitazone / Generic mfg.
Trial completion:  Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance (clinicaltrials.gov) -  Jun 27, 2012
P1/2, N=77, Completed,  Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Enrollment change: Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up (clinicaltrials.gov) - Jun 26, 2012
P=N/A, N=1424, Completed, Sponsor: University Hospital, Essen
Active, not recruiting --> Completed N=1000 --> 1424

|||||||||| Review: Meta-analyses of the Effect of Tree Nuts on Glycemic Control and Features of the Metabolic Syndrome (clinicaltrials.gov) - Jun 26, 2012
P=N/A, N=1, Active, not recruiting, Sponsor: John Sievenpiper

|||||||||| Trial completion: Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up (clinicaltrials.gov) - Jun 26, 2012
P=N/A, N=1424, Completed, Sponsor: University Hospital, Essen
N=1000 --> 1424 Recruiting --> Completed

|||||||||| New P4 trial: Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome (clinicaltrials.gov) - Jun 18, 2012
P4, N=732, Completed, Sponsor: Birjand University of Medical Sciences

|||||||||| Trial completion: A 4-month Intervention of Antioxidant Supplementation in Overweight Children (clinicaltrials.gov) - Jun 17, 2012
P=N/A, N=45, Completed, Sponsor: Swiss Federal Institute of Technology
Recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Clinical: Acute Effects of Tocotrienols on Insulin Sensitivity and Metabolic Risk Markers in Individuals at Risk for Metabolic Syndrome (clinicaltrials.gov) - Jun 15, 2012
P=N/A, N=30, Recruiting, Sponsor: Malaysia Palm Oil Board

|||||||||| Trial completion: Yellow Pea Protein and Fibre and Short Term Food Intake (clinicaltrials.gov) - Jun 13, 2012
P=N/A, N=20, Completed, Sponsor: University of Toronto
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: Effect of Consuming Beans for One Month on Blood Lipids, Satiety, Intake Regulation and Body Weight (clinicaltrials.gov) - Jun 13, 2012
P=N/A, N=14, Completed, Sponsor: University of Toronto
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: Yellow Pea Fractions and Short-term Food Intake, Subjective Appetite and Glycemic Response (clinicaltrials.gov) - Jun 12, 2012
P=N/A, N=20, Completed, Sponsor: University of Toronto
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Enrollment change: Pilot Study of Metabolic Syndromes and HIV Infections in Indian Tibetans (clinicaltrials.gov) - May 20, 2012
P=N/A, N=137, Completed, Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Active, not recruiting --> Completed N=2000 --> 137

|||||||||| Trial completion: Pilot Study of Metabolic Syndromes and HIV Infections in Indian Tibetans (clinicaltrials.gov) - May 20, 2012
P=N/A, N=137, Completed, Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
N=2000 --> 137 Recruiting --> Completed

||||||||||  omega-3 ethylester concentrate / Generic mfg.
New P3 trial:  HEARTS: Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (clinicaltrials.gov) -  May 14, 2012
P3, N=338, Recruiting,  Sponsor: Beth Israel Deaconess Medical Center

|||||||||| Trial completion: Meta-Health: Partnership Programs to Reduce Cardiovascular Disparities- Morehouse- Emory Partnership (clinicaltrials.gov) - May 14, 2012
P2, N=680, Completed, Sponsor: Emory University
Recruiting --> Completed Recruiting --> Completed

|||||||||| New P3 trial: Effects of Intragastric Balloon on Bone, Metabolic and Respiratory Parameters (clinicaltrials.gov) - May 13, 2012
P3, N=50, Active, not recruiting, Sponsor: Federal University of Rio de Janeiro

|||||||||| Trial completion: Improving the Management of Obesity in Primary Care Practice (The Power-UP Trial) (clinicaltrials.gov) - May 13, 2012
P3, N=390, Completed, Sponsor: University of Pennsylvania
Recruiting --> Completed Active, not recruiting --> Completed

|||||||||| New P1 trial: Effect of an Iridoid Enriched Beverage on Skin Autofluorescence (clinicaltrials.gov) - May 9, 2012
P1, N=48, Active, not recruiting, Sponsor: Tahitian Noni International, Inc.

||||||||||  pitavastatin / Generic mfg.
New P1 trial:  CAPITAIN: Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome (clinicaltrials.gov) -  May 8, 2012
P1, N=14, Completed,  Sponsor: Kowa Research Europe

|||||||||| Clinical: Risk Factor Analysis for Developing Metabolic Syndrome in Korean Adults (clinicaltrials.gov) - May 7, 2012
P=N/A, N=1000, Recruiting, Sponsor: Korea University

|||||||||| Enrollment closed, IO biomarker: The Effect of Whole Beans on Inflammation and Satiety (clinicaltrials.gov) - May 7, 2012
P=N/A, N=12, Active, not recruiting, Sponsor: University of California, Davis
Active, not recruiting --> Completed Recruiting --> Active, not recruiting

|||||||||| Enrollment closed: Treatment of Metabolic Syndrome in a Community Mental Health Center (clinicaltrials.gov) - May 7, 2012
P=N/A, N=150, Active, not recruiting, Sponsor: The University of Texas Health Science Center at San Antonio
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting

|||||||||| Enrollment open: Risk Factor Analysis for Coronary Atherosclerosis Measured by MDCT (clinicaltrials.gov) - May 6, 2012
P=N/A, N=150, Recruiting, Sponsor: Korea University
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting

|||||||||| Enrollment closed: GSEMetS: Grape Seed Extract and Postprandial Oxidation and Inflammation (clinicaltrials.gov) - Apr 30, 2012
P=N/A, N=12, Active, not recruiting, Sponsor: University of California, Davis
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting

|||||||||| Enrollment change: ArtStiff: Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial Protection (clinicaltrials.gov) - Apr 25, 2012
P3, N=133, Completed, Sponsor: Daiichi Sankyo Europe, GmbH
Recruiting --> Active, not recruiting N=318 --> 133

|||||||||| New P3 trial: CHANGE -it is About Life (clinicaltrials.gov) - Apr 24, 2012
P3, N=450, Not yet recruiting, Sponsor: Mental Health Services in the Capital Region, Denmark

|||||||||| Enrollment closed: Effect of Dietary Macronutrient Composition (clinicaltrials.gov) - Apr 19, 2012
P=N/A, N=24, Active, not recruiting, Sponsor: University of Texas Southwestern Medical Center
N=318 --> 133 Recruiting --> Active, not recruiting

|||||||||| New P2 trial, Surgery, Bariatric surgery: ADIII: Effect of Bariatric Surgery "Digestive Adaptations III" on Cardiovascular Risk (clinicaltrials.gov) - Apr 17, 2012
P2, N=30, Recruiting, Sponsor: University of Sao Paulo

|||||||||| Trial completion: Effect of Dietary Fibre and Whole Grain on the Metabolic Syndrome (clinicaltrials.gov) - Apr 17, 2012
P=N/A, N=15, Completed, Sponsor: Aarhus University Hospital
Recruiting --> Active, not recruiting Recruiting --> Completed

|||||||||| Enrollment closed, Compliance: TELEBPMET: Blood Pressure Control and Compliance to Treatment in Hypertensive Patients With Metabolic Syndrome: a Study Based on Home Blood Pressure Telemonitoring and Assessment of Psychological Determinants (clinicaltrials.gov) - Apr 16, 2012
P=N/A, N=254, Active, not recruiting, Sponsor: Italian Institute of Telemedicine
Recruiting --> Completed Completed --> Active, not recruiting

|||||||||| Trial completion: SYSDIET: The Effect of Nordic Recommended Diet on the Features of Metabolic Syndrome - Multicentre Study (clinicaltrials.gov) - Apr 15, 2012
P=N/A, N=167, Completed, Sponsor: Marjukka Kolehmainen
Completed --> Active, not recruiting Active, not recruiting --> Completed

||||||||||  Januvia (sitagliptin) / Merck (MSD)
Enrollment change:  Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome (clinicaltrials.gov) -  Apr 11, 2012
P4, N=24, Completed,  Sponsor: Vanderbilt University
Active, not recruiting --> Completed N=96 --> 24

|||||||||| Clinical: OPUS School Meal Study - Cross Sectional Analyses From Baseline Investigations (clinicaltrials.gov) - Apr 11, 2012
P=N/A, N=834, Completed, Sponsor: AAstrup

|||||||||| Enrollment change: FLAB: Is Fructose Linked to Adiposity in Babies? (clinicaltrials.gov) - Apr 10, 2012
P=N/A, N=40, Completed, Sponsor: University of California, San Francisco
N=96 --> 24 N=100 --> 40

|||||||||| Clinical: Acute Effects of Dietary Fats and Carbohydrate in Subjects With Metabolic Syndrome (clinicaltrials.gov) - Apr 2, 2012
P=N/A, N=30, Recruiting, Sponsor: Malaysia Palm Oil Board

||||||||||  pitavastatin / Generic mfg.
Trial completion:  ProPit: Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome (clinicaltrials.gov) -  Mar 27, 2012
P4, N=187, Completed,  Sponsor: JW Pharmaceutical
N=100 --> 40 Recruiting --> Completed

|||||||||| Trial initiation date: Garlic4: Effect of Aged Garlic Extract on Atherosclerosis (clinicaltrials.gov) - Mar 26, 2012
P4, N=65, Recruiting, Sponsor: Los Angeles Biomedical Research Institute
Recruiting --> Completed Initiation date: Feb 2012 --> May 2012

|||||||||| Enrollment change: Coenzyme Q10 and Vitamin A, C, E in Relation to the Oxidative Stress, Antioxidant Enzyme Activity and Inflammation in Subjects With Metabolic Syndrome (clinicaltrials.gov) - Mar 22, 2012
P=N/A, N=72, Completed, Sponsor: Chung Shan Medical University
Initiation date: Feb 2012 --> May 2012 N=200 --> 72